Skip to content

Michael Anstey

Michael Anstey

Michael Anstey brings expertise in the healthcare and life sciences sectors through his experience in strategy consulting, venture capital investing, and research and academia.
Mike is currently a Principal in the Toronto office of The Boston Consulting Group (BCG). He is a core member of the healthcare practice and works closely with multinational biopharma and medtech companies to identify their highest-value opportunities, address their most critical challenges and transform their enterprises.
Prior to joining BCG, Mike was an investment analyst and Kauffman Fellow at Oxford Capital Partners, a UK-based venture capital firm that specializes in investing in early-stage science and technology businesses. Mike was responsible for identifying, executing and monitoring investments in the healthcare and life sciences sectors. Before Oxford Capital, Mike was a researcher in the field of neuroscience at the Universities of Oxford, Cambridge, and Sydney. He has authored papers published in a number of leading academic journals including Current Biology and Science.
Mike graduated with a 1st Class Honors degree in biology from Queen’s University in Canada, and earned his PhD in zoology from Oxford University where he was the Hope Scholar.
Highlights

  • Principal, The Boston Consulting Group (Canada)
  • Investment Analyst, Oxford Capital Partners (UK)
  • Kauffman Fellow
  • PhD in zoology, Oxford University